Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Calpulalpan
Clinical trial register · Mexico

Clinical Trials in Calpulalpan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Mexico and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1585 matching records held by the registry are in this view. Synced 09 Oct 2026, 03:18 UTC
1585
Studies in scope
all four open statuses
715
Recruiting now
open to new participants
254
Lead sponsors
across recruiting studies
Top sites
Mexico City 591 Monterrey 374 Guadalajara 348 Chihuahua City 175 Mérida 133
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
PureTech1
Site location
Mexico City591 Monterrey374 Guadalajara348 Chihuahua City175 Mérida133
All 197 locations
Target enrolment
to

Trials with a site in Calpulalpan

1 of 1585 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Mexico
Start
Active, closed
PureTech
Phase 2
240
Monterrey, San Nicolás de los Garza, Calpulalpan, Oaxaca City, San Pedro Garza García
2022-07-22
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Mexican investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-mexico/city/calpulalpan

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Mexico and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,585 studies in total at the last sync on 09 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Calpulalpan.

How many clinical trials are recruiting in Calpulalpan?

0 of the 1 studies on this page are recruiting new participants as of the 09 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Calpulalpan), 1 studies
PhaseStudiesRecruitingShare
Phase 210100%

Most active sponsors

Lead sponsors with the most studies (Calpulalpan)
Lead sponsorStudiesRecruiting
PureTech10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.